Antimicrobial susceptibility of coagulase-negative staphylococci.
作者信息
Archer G L, Climo M W
机构信息
Department of Medicine, Medical College of Virginia, Virginia Commonwealth University, Richmond 23298-0049.
出版信息
Antimicrob Agents Chemother. 1994 Oct;38(10):2231-7. doi: 10.1128/AAC.38.10.2231.
Abstract
摘要
相似文献
1
Antimicrobial susceptibility of coagulase-negative staphylococci.凝固酶阴性葡萄球菌的抗菌药敏性
Antimicrob Agents Chemother. 1994 Oct;38(10):2231-7. doi: 10.1128/AAC.38.10.2231.
2
Antimicrobial susceptibility of staphylococci isolated from otitis externa in dogs.从犬外耳炎分离出的葡萄球菌的抗菌药敏性
Lett Appl Microbiol. 2000 Jul;31(1):42-5. doi: 10.1046/j.1472-765x.2000.00759.x.
3
Teicoplanin-resistant coagulase-negative staphylococci.
Lancet. 1987 Jan 3;1(8523):39. doi: 10.1016/s0140-6736(87)90724-0.
4
Patterns of multidrug resistance among methicillin-resistant hospital isolates of coagulase-positive and coagulase-negative staphylococci collected in the international multicenter study RESIST in 1997 and 1998.1997年和1998年在国际多中心研究RESIST中收集的凝固酶阳性和凝固酶阴性葡萄球菌的耐甲氧西林医院分离株中的多重耐药模式。
Microb Drug Resist. 2000 Fall;6(3):199-211. doi: 10.1089/mdr.2000.6.199.
5
Antimicrobial susceptibility of 200 blood isolates of coagulase-negative staphylococci to 20 antimicrobial agents.
Scand J Infect Dis. 1984;16(4):345-8. doi: 10.3109/00365548409073959.
6
Antimicrobial resistance of coagulase-negative staphylococci from a Kuwait hospital.科威特一家医院凝固酶阴性葡萄球菌的抗菌耐药性
Microb Drug Resist. 1995 Winter;1(4):315-20. doi: 10.1089/mdr.1995.1.315.
7
In vitro antimicrobial susceptibilities of oxacillin-resistant coagulase negative staphylococci.耐苯唑西林凝固酶阴性葡萄球菌的体外抗菌药敏试验
Methods Find Exp Clin Pharmacol. 1985 Jun;7(6):333-5.
8
Detection and characterization of methicillin-resistant and susceptible coagulase-negative staphylococci in milk from cows with clinical mastitis in Tunisia.检测和鉴定突尼斯临床型乳腺炎奶牛乳中耐甲氧西林和敏感凝固酶阴性葡萄球菌。
Int J Antimicrob Agents. 2018 Dec;52(6):930-935. doi: 10.1016/j.ijantimicag.2018.07.026. Epub 2018 Aug 3.
9
Synergy of combinations of vancomycin, gentamicin, and rifampin against methicillin-resistant, coagulase-negative staphylococci.万古霉素、庆大霉素和利福平联合用药对耐甲氧西林凝固酶阴性葡萄球菌的协同作用。
Antimicrob Agents Chemother. 1983 Jun;23(6):932-4. doi: 10.1128/AAC.23.6.932.
10
Antimicrobial susceptibility of coagulase-negative staphylococci isolated from bovine mastitis in Argentina.
J Dairy Sci. 2002 Aug;85(8):1913-7. doi: 10.3168/jds.s0022-0302(02)74267-7.
引用本文的文献
1
Targeting Chronic Biofilm Infections With Patient-derived Phages: An In Vitro and Ex Vivo Proof-of-concept Study in Patients With Left Ventricular Assist Devices.利用患者来源的噬菌体靶向慢性生物膜感染：一项针对左心室辅助装置患者的体外和离体概念验证研究
Open Forum Infect Dis. 2025 Mar 20;12(4):ofaf158. doi: 10.1093/ofid/ofaf158. eCollection 2025 Apr.
2
The Possibility of Ceftolozane/Tazobactam-Resistant Pseudomonas aeruginosa Emergence After Two Days of Antibiotic Therapy: A Case Report.抗生素治疗两天后出现对头孢洛扎/他唑巴坦耐药的铜绿假单胞菌的可能性：一例报告
Cureus. 2025 Feb 18;17(2):e79207. doi: 10.7759/cureus.79207. eCollection 2025 Feb.
3
Evaluating the performance of the Alere PBP2a SA Culture Colony Test with the Vitek 2 Antimicrobial Susceptibility Test Card System as reference standard in coagulase-negative species.以Vitek 2药敏试验卡系统为参考标准，评估Alere PBP2a SA培养菌落试验在凝固酶阴性菌中的性能。
Infect Med (Beijing). 2024 Aug 6;3(3):100126. doi: 10.1016/j.imj.2024.100126. eCollection 2024 Sep.
4
Daptomycin and Ceftaroline Combination Therapy in Complicated Endovascular Infections Caused by Methicillin-Resistant Staphylococcus epidermidis.达托霉素与头孢洛林联合治疗耐甲氧西林表皮葡萄球菌引起的复杂性血管内感染
Cureus. 2024 Feb 13;16(2):e54134. doi: 10.7759/cureus.54134. eCollection 2024 Feb.
5
It's Not You, It's SOSA: A Case Study on Breaking Up With an FDA-Cleared Susceptibility Testing System's Oxacillin Results for spp. Other Than and .不是你的问题，是索萨（SOSA）的问题：关于摒弃美国食品药品监督管理局（FDA）批准的药敏试验系统针对除 和 之外的 菌的苯唑西林结果的案例研究
Open Forum Infect Dis. 2022 Aug 17;9(9):ofac421. doi: 10.1093/ofid/ofac421. eCollection 2022 Sep.
6
Susceptibility Testing by Volatile Organic Compound Detection Direct from Positive Blood Cultures: A Proof-of-Principle Laboratory Study.直接从阳性血培养物中检测挥发性有机化合物进行药敏试验：一项原理验证实验室研究。
Antibiotics (Basel). 2022 May 24;11(6):705. doi: 10.3390/antibiotics11060705.
7
, Infections: Are CoNS Cons?感染：凝固酶阴性葡萄球菌真的是“凝固酶阴性”吗？
Indian J Crit Care Med. 2020 Aug;24(8):716-718. doi: 10.5005/jp-journals-10071-23523.
8
Evaluation of Teicoplanin Resistance Detected by Automated System in Coagulase Negative Staphylococci: A Comparison with Gradient Test and Broth Microdilution Methods.自动化系统检测凝固酶阴性葡萄球菌中替考拉宁耐药性的评估：与梯度试验和肉汤微量稀释法的比较
Curr Microbiol. 2020 Nov;77(11):3355-3360. doi: 10.1007/s00284-020-02144-7. Epub 2020 Aug 4.
9
Tailoring Antimicrobial Susceptibility Testing to Individual Species of Coagulase-Negative Staphylococci: Next Up, Staphylococcus epidermidis.针对凝固酶阴性葡萄球菌的不同种属进行抗菌药物敏感性试验的定制化：下一个，表皮葡萄球菌。
J Clin Microbiol. 2019 Nov 22;57(12). doi: 10.1128/JCM.01391-19. Print 2019 Dec.
10
Osteomyelitis: Case Report.骨髓炎：病例报告。
Glob Pediatr Health. 2019 Mar 7;6:2333794X19833736. doi: 10.1177/2333794X19833736. eCollection 2019.
本文引用的文献
1
RP 59500, a new streptogramin highly active against recent isolates of North American staphylococci.RP 59500，一种对北美葡萄球菌近期分离株具有高度活性的新型链阳性菌素。
Diagn Microbiol Infect Dis. 1993 Mar-Apr;16(3):223-6. doi: 10.1016/0732-8893(93)90113-l.
2
Distribution of genes encoding erythromycin ribosomal methylases and an erythromycin efflux pump in epidemiologically distinct groups of staphylococci.红霉素核糖体甲基化酶编码基因及红霉素外排泵在不同流行病学特征葡萄球菌群体中的分布
J Antimicrob Chemother. 1993 Feb;31(2):211-7. doi: 10.1093/jac/31.2.211.
3
In vitro and in vivo antibacterial activities of the glycylcyclines, a new class of semisynthetic tetracyclines.新型半合成四环素类——甘氨酰环素的体外和体内抗菌活性
Antimicrob Agents Chemother. 1993 Nov;37(11):2270-7. doi: 10.1128/AAC.37.11.2270.
4
Analysis of pristinamycin-resistant Staphylococcus epidermidis isolates responsible for an outbreak in a Parisian hospital.对导致巴黎一家医院爆发感染的耐普ristinamycin的表皮葡萄球菌分离株的分析。
Antimicrob Agents Chemother. 1993 Oct;37(10):2159-65. doi: 10.1128/AAC.37.10.2159.
5
Comparative in vitro activity of DU-6859a, a new fluoroquinolone agent, against gram-positive cocci.新型氟喹诺酮类药物DU-6859a对革兰氏阳性球菌的体外活性比较
Antimicrob Agents Chemother. 1994 Mar;38(3):611-5. doi: 10.1128/AAC.38.3.611.
6
In vitro activities of two glycylcyclines against gram-positive bacteria.两种甘氨酰环素对革兰氏阳性菌的体外活性。
Antimicrob Agents Chemother. 1994 Mar;38(3):534-41. doi: 10.1128/AAC.38.3.534.
7
New quinolones and gram-positive bacteria.新型喹诺酮类药物与革兰氏阳性菌
Antimicrob Agents Chemother. 1994 Feb;38(2):163-9. doi: 10.1128/AAC.38.2.163.
8
Two controlled trials of rifabutin prophylaxis against Mycobacterium avium complex infection in AIDS.两项关于利福布汀预防艾滋病患者鸟分枝杆菌复合体感染的对照试验。
N Engl J Med. 1993 Sep 16;329(12):828-33. doi: 10.1056/NEJM199309163291202.
9
Update on clinical significance of coagulase-negative staphylococci.凝固酶阴性葡萄球菌临床意义的最新进展
Clin Microbiol Rev. 1994 Jan;7(1):117-40. doi: 10.1128/CMR.7.1.117.
10
In vitro antibacterial activities of PD 138312 and PD 140248, new fluoronaphthyridines with outstanding gram-positive potency.PD 138312和PD 140248这两种新型氟萘啶类化合物的体外抗菌活性，它们对革兰氏阳性菌具有出色的抗菌效力。
Antimicrob Agents Chemother. 1993 Dec;37(12):2563-70. doi: 10.1128/AAC.37.12.2563.
Zotero 插件